Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Second-Line Antiretroviral Therapy in Sub-Saharan Africa: It Is Time to Mind the Gaps

Published:2017-12 Issue:12 Volume:33 Page:1181-1184
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Murphy Richard A.¹,Court Richard²,Maartens Gary²,Sunpath Henry³

Affiliation:

1. Division of Infectious Diseases, Los Angeles Biomedical Research Institute, Harbor-UCLA Medical Center, Torrance, California.

2. Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

3. Division of Infectious Diseases, University of KwaZulu-Natal, Durban, South Africa.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.2017.0134

Reference8 articles.

1. The need for second-line antiretroviral therapy in adults in sub-Saharan Africa up to 2030: a mathematical modelling study

2. Delayed switch of antiretroviral therapy after virologic failure associated with elevated mortality among HIV-infected adults in Africa

3. The Effect of Switching to Second-Line Antiretroviral Therapy on the Risk of Opportunistic Infections Among Patients Infected With Human Immunodeficiency Virus in Northern Tanzania

4. Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa

5. Early outcomes and the virological effect of delayed treatment switching to second-line therapy in an antiretroviral roll-out programme in South Africa

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and tolerability of dolutegravir-based ART regimen in Durban, South Africa: a cohort study;BMC Infectious Diseases;2024-03-21

2. Diagnostic accuracy of a point‐of‐care urine tenofovir assay, and associations with HIV viraemia and drug resistance among people receiving dolutegravir and efavirenz‐based antiretroviral therapy;Journal of the International AIDS Society;2023-09

3. Point-of-Care Viral Load Testing to Manage HIV Viremia During the Rollout of Dolutegravir-Based ART in South Africa: A Randomized Feasibility Study (POwER);JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-08-15

4. Second-Line Antiretroviral Treatment Outcomes and Predictors in Tigray Region, Ethiopia;Infection and Drug Resistance;2023-07

5. Machine learning to predict virological failure among HIV patients on antiretroviral therapy in the University of Gondar Comprehensive and Specialized Hospital, in Amhara Region, Ethiopia, 2022;BMC Medical Informatics and Decision Making;2023-04-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3